Breast Cancer Clinical Trials in Tokyo, Tokyo
2 recruitingTokyo, Tokyo, Japan
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Triple-Negative Breast CancerEndometrial CancerPrimary Peritoneal Carcinoma+12 more
Genmab764 enrolled67 locationsNCT05579366
Recruiting
Phase 3
Metastasis-directed Therapy for Oligometastases of Breast Cancer
Breast CancerMetastatic Breast CancerOligometastasis
Tokyo Medical and Dental University340 enrolled1 locationNCT06135714